FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2786118982> ?p ?o ?g. }

• W2786118982 endingPage "1125" @default.
• W2786118982 startingPage "1116" @default.
• W2786118982 abstract "Adoption of varicella immunization in Europe is limited due to a predicted increase in the incidence of herpes zoster (HZ) resulting from a removal of exogenous boosting by varicella vaccination. Most available assessments of immunization strategies only considered universal varicella vaccination (alone or in combination with HZ by the live vaccine). The development of a new subunit recombinant zoster vaccine may provide new perspectives of HZ control.We used a mathematical model for VZV in Norway based on the progressive immunity formulation of exogenous boosting. We evaluated a complete range of alternative immunization options against varicella and HZ including both universal and targeted varicella vaccination, either alone or with zoster immunization, and zoster immunization alone. We considered all values of the boosting intensity consistent with the Norwegian HZ incidence and compared the performance of the currently available live vaccine vs. a new recombinant vaccine.Universal varicella vaccination alone resulted in a marked increase in the incidence of HZ under all scenarios considered. Even under the most favorable hypotheses on the magnitude of the boosting intensity, this increase could be mitigated only by a parallel HZ immunization with a recombinant vaccine, assuming a long duration of protection. Targeted varicella immunization of adolescents resulted in a modest increase in the HZ incidence which could be counterbalanced by both the live and, especially, the recombinant vaccine.Given current knowledge on HZ pathogenesis and exogenous boosting, targeted varicella vaccination of adolescents was the only strategy that was not predicted to impact the epidemiology of HZ, and therefore it may represent a suitable alternative to universal vaccination. These results are aimed to support vaccine policy decisions in Norway and other countries with a similar VZV epidemiology." @default.
• W2786118982 created "2018-02-23" @default.
• W2786118982 creator A5007171888 @default.
• W2786118982 creator A5018526524 @default.
• W2786118982 creator A5020529620 @default.
• W2786118982 creator A5022638011 @default.
• W2786118982 creator A5033487017 @default.
• W2786118982 creator A5077184948 @default.
• W2786118982 date "2018-02-01" @default.
• W2786118982 modified "2023-09-23" @default.
• W2786118982 title "Modeling the impact of combined vaccination programs against varicella and herpes zoster in Norway" @default.
• W2786118982 cites W1737209335 @default.
• W2786118982 cites W1914544186 @default.
• W2786118982 cites W1963910020 @default.
• W2786118982 cites W1965377946 @default.
• W2786118982 cites W1972993372 @default.
• W2786118982 cites W1993113905 @default.
• W2786118982 cites W1993340773 @default.
• W2786118982 cites W2020760546 @default.
• W2786118982 cites W2031261545 @default.
• W2786118982 cites W2032599402 @default.
• W2786118982 cites W2062995016 @default.
• W2786118982 cites W2064317635 @default.
• W2786118982 cites W2067450634 @default.
• W2786118982 cites W2071309410 @default.
• W2786118982 cites W2072366847 @default.
• W2786118982 cites W2077233193 @default.
• W2786118982 cites W2093041693 @default.
• W2786118982 cites W2098966371 @default.
• W2786118982 cites W2101730316 @default.
• W2786118982 cites W2101866565 @default.
• W2786118982 cites W2112507327 @default.
• W2786118982 cites W2116724909 @default.
• W2786118982 cites W2124903732 @default.
• W2786118982 cites W2146899219 @default.
• W2786118982 cites W2154714320 @default.
• W2786118982 cites W2155485711 @default.
• W2786118982 cites W2160159455 @default.
• W2786118982 cites W2164028166 @default.
• W2786118982 cites W2166442897 @default.
• W2786118982 cites W2305604600 @default.
• W2786118982 cites W2329705186 @default.
• W2786118982 cites W2346467460 @default.
• W2786118982 cites W2416309777 @default.
• W2786118982 cites W2513102169 @default.
• W2786118982 cites W2519957152 @default.
• W2786118982 cites W2523820170 @default.
• W2786118982 cites W2537587263 @default.
• W2786118982 cites W2607371863 @default.
• W2786118982 cites W2616147945 @default.
• W2786118982 cites W2729777489 @default.
• W2786118982 cites W4211188326 @default.
• W2786118982 cites W4297399162 @default.
• W2786118982 cites W2168077760 @default.
• W2786118982 doi "https://doi.org/10.1016/j.vaccine.2018.01.038" @default.
• W2786118982 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29366704" @default.
• W2786118982 hasPublicationYear "2018" @default.
• W2786118982 type Work @default.
• W2786118982 sameAs 2786118982 @default.
• W2786118982 citedByCount "12" @default.
• W2786118982 countsByYear W27861189822018 @default.
• W2786118982 countsByYear W27861189822019 @default.
• W2786118982 countsByYear W27861189822020 @default.
• W2786118982 countsByYear W27861189822021 @default.
• W2786118982 countsByYear W27861189822022 @default.
• W2786118982 crossrefType "journal-article" @default.
• W2786118982 hasAuthorship W2786118982A5007171888 @default.
• W2786118982 hasAuthorship W2786118982A5018526524 @default.
• W2786118982 hasAuthorship W2786118982A5020529620 @default.
• W2786118982 hasAuthorship W2786118982A5022638011 @default.
• W2786118982 hasAuthorship W2786118982A5033487017 @default.
• W2786118982 hasAuthorship W2786118982A5077184948 @default.
• W2786118982 hasConcept C120665830 @default.
• W2786118982 hasConcept C121332964 @default.
• W2786118982 hasConcept C159047783 @default.
• W2786118982 hasConcept C187212893 @default.
• W2786118982 hasConcept C203014093 @default.
• W2786118982 hasConcept C22070199 @default.
• W2786118982 hasConcept C2522874641 @default.
• W2786118982 hasConcept C2776159415 @default.
• W2786118982 hasConcept C2780473352 @default.
• W2786118982 hasConcept C2780801004 @default.
• W2786118982 hasConcept C61511704 @default.
• W2786118982 hasConcept C71924100 @default.
• W2786118982 hasConcept C8891405 @default.
• W2786118982 hasConceptScore W2786118982C120665830 @default.
• W2786118982 hasConceptScore W2786118982C121332964 @default.
• W2786118982 hasConceptScore W2786118982C159047783 @default.
• W2786118982 hasConceptScore W2786118982C187212893 @default.
• W2786118982 hasConceptScore W2786118982C203014093 @default.
• W2786118982 hasConceptScore W2786118982C22070199 @default.
• W2786118982 hasConceptScore W2786118982C2522874641 @default.
• W2786118982 hasConceptScore W2786118982C2776159415 @default.
• W2786118982 hasConceptScore W2786118982C2780473352 @default.
• W2786118982 hasConceptScore W2786118982C2780801004 @default.
• W2786118982 hasConceptScore W2786118982C61511704 @default.
• W2786118982 hasConceptScore W2786118982C71924100 @default.
• W2786118982 hasConceptScore W2786118982C8891405 @default.

• next